CIAS
MRNS

Capital Investment Advisory Services’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Capital Investment Advisory Services’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6
Closed – – 1297
2019
Q3 		$0 Hold
6
– – ﹤0.01% 1485
2019
Q2 		$0 Hold
6
– – ﹤0.01% 1467
2019
Q1 		$0 Hold
6
– – ﹤0.01% 1293
2018
Q4 		$0 Buy
+6
New +$121 ﹤0.01% 1223

Other funds holding MRNS

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Capital Investment Advisory Services's MRNS Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2019, closing a stake of 6 shares.

Capital Investment Advisory Services first reported a position in MRNS in Q4 2018 and held it in 4 quarters. The position peaked at $0 in Q3 2019. 79 funds tracked by Wall St. Rank hold MRNS as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 6 Marinus Pharmaceuticals, Inc shares in Q4 2019.
  • Capital Investment Advisory Services first reported a position in Marinus Pharmaceuticals, Inc in Q4 2018 and held it in 4 quarters.
  • Capital Investment Advisory Services's Marinus Pharmaceuticals, Inc position peaked at $0 in Q3 2019.
  • 79 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.